Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of clopidogrel and aspirin-induced platelet inhibition with platelet concentrates in healthy volunteers
2009-018108-17Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clopidogrel, aspirin and autologous platelet rich gel, sponsored by Medical University of Graz. Primary endpoint: Change in ADP-induced platelet aggregation after platelet concentrate transfusion. Started Feb 2010; status: completed.
02
Drugs
clopidogrelaspirinautologous platelet rich gel
Beyond the preview
Go deeper on 2009-018108-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018108-17.